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To the Editor: The prevalence and impact of outcome reporting bias in randomized controlled trials 
(RCTs) within Cochrane systematic reviews has previously been investigated [1]. A recommendation 
from this research was that studies should not be excluded from reviews on the basis that there was 
‘no relevant outcome data’ (NROD), as failure to report on review outcomes does not imply that the 
outcomes were not measured. Moreover, this recommendation is an expected methodological 
standard for Cochrane intervention reviews [2]. Quality assurance screening of reviews carried out 
by the Cochrane Editorial Unit (CEU) has identified that reviews still exclude studies on the basis of 
NROD. We investigated the proportion of Cochrane reviews excluding studies on the basis of NROD 
and whether the proportion had changed following the implementation of review screening.  
 
Methods.  New Cochrane reviews were included from all Cochrane review groups published from 
June to August in 2013 (pre-screening), 2014 (screening of all new reviews), 2015 (screening of all 
new reviews) and 2016 (screening based on a referral basis by the Cochrane review groups). For 
each included review, investigators extracted the number of included studies, the number of 
excluded studies and the number of excluded studies due to NROD. To determine whether studies 
were excluded due to NROD, the relevant methods, results and characteristics of studies section of 
the review were scrutinised. Any uncertainties regarding the reasons for excluded studies were 
resolved through discussion between the investigators. If a review excluded a study due to NROD, 
the review protocol was checked to ascertain whether exclusion based on NROD was a pre-specified 
criterion for study exclusion. The proportion of reviews excluding studies due to NROD for each year 
was calculated. Relative risks (RR) and 95% confidence intervals (CI) were calculated to determine 
whether full screening or referred screening reduced the number of reviews excluding studies due to 
NROD.       
 
Results.  434 new reviews were identified in the reference period. Over a quarter of reviews 
excluded studies based on NROD in the pre-screening period, while this figure reduced to under a 
quarter in the new review screen and referred screening phases (TABLE). The result was almost 
significant for a reduced risk of reviews excluding studies due to NROD if all new reviews were 
screened (RR 0.91 CI (0.81, 1.03)) or were referred for screening (RR 0.93 CI (0.80, 1.08)) compared 
to pre-screening. Results were similar when removing reviews that pre-specified that studies would 
be excluded due to NROD.    
 
Comment.  Since the CEU introduced the screening programme the percentage of reviews excluding 
studies on the basis of NROD has reduced. However, around a fifth of reviews are still excluding 
studies based on the lack of reporting of outcomes of interest in trial reports. Restricting synthesis to 
only studies that report on relevant outcome constitutes research waste, if other, otherwise eligible 
studies are discarded based on failure to report outcome data. Excluding outcome data from meta-
analysis in this way has previously been shown to overestimate the treatment effect, which may 
potentially lead to incorrect recommendations regarding treatment [1]. Potential missing outcome 
data from excluded studies could be obtained from contact with trial authors or results posted on 
trial registries. Methods are available to help authors identify whether outcomes are likely to have 
been measured [1, 3] and sensitivity analyses have been developed to assess whether the exclusion 
of data from studies is likely to impact on the results [4]. Future strategies are needed (e.g. specific 
checks at an earlier point in the process) to prevent authors publishing reviews with NROD as a 
reason for exclusion and reasons for exclusions need to be improved. 
 
 
 Cohort data Data on reviews that exclude due to NROD 
Year No. of 
reviews 
Summary 
of No. 
included 
studies 
 
Median 
(IQR) 
Summary 
of No. 
excluded 
studies 
 
Median 
(IQR) 
Summary of 
No. reviews 
that excluded 
studies due to 
NROD (%)1  
Pre-specified 
in protocol 
that studies 
would be 
excluded due 
to NROD (%)2 
Summary of 
No. studies 
excluded 
due to 
NROD 
 
Median 
(IQR) [%]3 
2013 (pre-
screening) 
144 6 (3, 14.25) 14 (5, 33.5) 
 
39  (27%) 6 (15%) 4 (2, 10) 
[31%] 
2014 (new 
review 
screening) 
91 6 (2, 12) 14 (5.5, 27) 17 (19%) 3 (18%) 4 (2, 7) 
[27%] 
2015 (new 
review 
screening) 
112 6 (2, 14) 14 (6, 33) 24 (21%) 5 (21%) 2 (1.75, 7) 
[24%] 
2016 
(referred 
screening) 
87 6 (2, 13.5) 14 (5, 
41.75) 
19 (22%) 2 (11%) 3 (1.5, 5) 
[45%] 
1. Denominator taken to be the number of reviews in each three month period 
2. Denominator taken to be the number of reviews that excluded studies due to NROD in each three month period 
3. Denominator taken from the number of reviews that excluded studies due to NROD and is the total number of included studies 
plus studies excluded due to NROD in each three month period 
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